Tiago Pina Cabral: Can Port Maintenance be Safely Extended to 24 Weeks After Treatment Completion?
Tiago Pina Cabral, Medical Oncology Resident at Western Lisbon Local Health Unit, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“New publication – PORT-24 study
Proud to share our latest work․
We explored a simple but clinically relevant question:
- Can port maintenance be safely extended to 24 weeks after treatment completion?
What we found:
- Very low complication rate (2.33/100 port-years)
- No infections over 250 port-years
- Outcomes comparable to standard 4–12 week protocols
Take-home message:
- In selected cancer survivors, less frequent maintenance may be safe, with clear benefits for patients and healthcare systems.
But let’s be clear:
- If a port is no longer needed, it should be removed.
- Extended intervals are not a substitute for appropriate device removal, they are an option when retention is clinically justified.
Less is more… but only in the right patient.”
Title: Extended maintenance intervals for implanted venous ports in oncology: A retrospective assessment of 24-week intervals (PORT-24 study)
Authors: Tiago Pina-Cabral, Cláudia Ricou, Maria Teresa Recio, Carina Nascimento, Carla Cabral, Raquel Ferreira, Francisca Ferraz de Liz, Sandra Ponte
Read the Full Article on The Journal of Vascular Access
Stay updated with Hemostasis Today.
-
Sep 6, 2026, 05:26Yousef Hindi: Unprovoked Left Renal Vein Thrombosis and Severe IDA – Long-Term Resolution and Dual-Energy CT Findings
-
Sep 6, 2026, 05:18Robert Brown: Standardizing Amniotic Fluid Embolism Diagnosis – SMFM and AFE Foundation Criteria
-
Sep 6, 2026, 04:45Mohammed Al Kanan: Early Identification of VTE Risk in Lung Cancer Patients
-
Sep 6, 2026, 04:38M. Ibrahim Siddique: Does Routine Triple Therapy Pay Off After Anterior STEMI?
-
Sep 6, 2026, 04:29Sandra Revill Tremulis: The Lp(a)HORIZON Topline Results Raise Important Questions Beyond Simply ‘Does Lowering Lp(a) Work?’
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment